Englewood Hospital and Medical Center   Report issue

Academic/Hospital Phase 2
Founded: Englewood NJ United States (1888)

Organization Overview

First Clinical Trial
2013
NCT01868984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Englewood Hospital and Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constriction, Pathologic (Phase 2)

Fistula (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 5